General Information of the Protein
Protein ID
PT00875
Protein Name
Tyrosine-protein kinase Lyn
Secondarily
Protein Name
Lck/Yes-related novel protein tyrosine kinase
V-yes-1 Yamaguchi sarcoma viral related oncogene homolog
p53Lyn
p56Lyn
Gene Name
LYN
Secondarily
Gene Name
JTK8
Sequence
MGCIKSKGKDSLSDDGVDLKTQPVRNTERTIYVRDPTSNKQQRPVPESQLLPGQRFQTKDPEEQGDIVVALYPYDGIHPDDLSFKKGEKMKVLEEHGEWWKAKSLLTKKEGFIPSNYVAKLNTLETEEWFFKDITRKDAERQLLAPGNSAGAFLIRESETLKGSFSLSVRDFDPVHGDVIKHYKIRSLDNGGYYISPRITFPCISDMIKHYQKQADGLCRRLEKACISPKPQKPWDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQP
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
TK protein kinase group
>
Tyrosine protein kinase Src family
Function
Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr-72'. Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation. Phosphorylates SCIMP on 'Tyr-107'; this enhances binding of SCIMP to TLR4, promoting the phosphorylation of TLR4, and a selective cytokine response to lipopolysaccharide in macrophages (By similarity). Phosphorylates CLNK (By similarity). Phosphorylates BCAR1/CAS and NEDD9/HEF1 (PubMed:9020138).
    Show/Hide
Uniprot ID
Primary ID:
P07948

Secondarily ID:
A0AVQ5
    Show/Hide
Ensembl ID
ENSG00000254087
HGNC ID
HGNC:6735
Subcellular Location
Cell membrane
Nucleus
Cytoplasm
Cytoplasm
Perinuclear region
Golgi apparatus
Membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000077 , Ba/F3
Compound ID Compound Name Compound Formula
CP0230192
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O2
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0309083
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-5-tert-butylthiophene-2-carboxamide
   Show/Hide
C27H27N7OS
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0147351
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide
   Show/Hide
C31H30F3N9O
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0268699
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-tert-butylpyridine-4-carboxamide
   Show/Hide
C28H28N8O
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0147359
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(4-ethylpiperazin-1-yl)-5-(trifluoromethyl)benzamide
   Show/Hide
C32H32F3N9O
 1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0150295
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-chloro-4-[(4-ethylpiperazin-1-yl)methyl]benzamide
   Show/Hide
C32H34ClN9O
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0166375
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C26H20F3N7O
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0136623
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C26H20F3N7O
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0309066
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-isopropylphenyl)-4-methylbenzamide
   Show/Hide
C28H27N7O
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0147352
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-tert-butylphenyl)-4-methylbenzamide
   Show/Hide
C29H29N7O
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0166378
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C30H24F3N9O
 1
1
IC50 = 28 nM
   TI
   LI
   LO
   TS
CP0485534
2-(4-(6-(6-(2-(2-chloro-6-methylphenylamino)-1H-benzo[d]imidazol-1-yl)pyrimidin-4-ylamino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethanol
   Show/Hide
C29H31ClN10O
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0147357
4-methyl-3-(1-(4-(3-(4-methylpiperazin-1-yl)propylamino)-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C33H35F3N10O
 1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
CP0227163
N-[4-methyl-3-[[1-[6-(3-morpholin-3-ylpropylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C33H33F3N8O2
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0388620
methyl N-[4-[7-amino-3-(3,4-dimethoxyphenyl)-5-(1-methylpiperidin-4-yl)oxypyrazolo[1,5-a]pyrimidin-6-yl]phenyl]carbamate
   Show/Hide
C28H32N6O5
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0166283
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-methylbenzamide
   Show/Hide
C26H23N7O
 1
1
IC50 = 82 nM
   TI
   LI
   LO
   TS
CP0278790
4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C34H36F3N9O
 1
1
IC50 = 84 nM
   TI
   LI
   LO
   TS
CP0289191
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-1-tert-butyl-5-[(4-methylpiperazin-1-yl)methyl]pyrazole-3-carboxamide
   Show/Hide
C32H39N11O
 1
1
IC50 = 88 nM
   TI
   LI
   LO
   TS
CP0166376
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-5-cyclopropyl-1H-pyrazole-3-carboxamide
   Show/Hide
C25H23N9O
 1
1
IC50 = 96 nM
   TI
   LI
   LO
   TS
CP0230191
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-(difluoromethoxy)phenyl)-4-methylbenzamide
   Show/Hide
C26H21F2N7O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0150292
4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C33H34F3N9O
 1
1
IC50 = 113 nM
   TI
   LI
   LO
   TS
CP0151357
N-[3-[[1-[6-(2-methoxyethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C29H26F3N7O2
 1
1
IC50 = 126 nM
   TI
   LI
   LO
   TS
CP0418567
3-[4-amino-7-[3-(hydroxymethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-5-yl]phenol
   Show/Hide
C17H18N4O2
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0290298
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-chlorobenzamide
   Show/Hide
C25H20ClN7O
 1
1
IC50 = 133 nM
   TI
   LI
   LO
   TS
CP0166281
3-(1-(6-(4-(dimethylamino)butylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C32H33F3N8O
 1
1
IC50 = 134 nM
   TI
   LI
   LO
   TS
CP0150291
3-(1-(6-(4-(diethylamino)butylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C34H37F3N8O
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0289193
N-[4-methyl-3-[[1-[6-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C34H36F3N9O
 1
1
IC50 = 149 nM
   TI
   LI
   LO
   TS
CP0061016
3-(4-Amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-phenol
   Show/Hide
C17H18N4O
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0294208
N-[4-methyl-3-[[1-[6-[2-(4-methylpiperazin-1-yl)ethylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C33H34F3N9O
 1
1
IC50 = 204 nM
   TI
   LI
   LO
   TS
CP0327707
N-(2-chloro-6-methylphenyl)-1-[6-[[5-(2-morpholin-4-ylethyl)pyridin-2-yl]amino]pyrimidin-4-yl]benzimidazol-2-amine
   Show/Hide
C29H29ClN8O
 1
1
IC50 = 215 nM
   TI
   LI
   LO
   TS
CP0227161
N-[3-[[1-[6-[4-(diethylamino)butylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C34H37F3N8O
 1
1
IC50 = 217 nM
   TI
   LI
   LO
   TS
CP0151356
N-[4-methyl-3-[[1-[6-(2-pyridin-2-ylethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C33H27F3N8O
 1
1
IC50 = 259 nM
   TI
   LI
   LO
   TS
CP0147354
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-bromophenyl)-4-methylbenzamide
   Show/Hide
C25H20BrN7O
 1
1
IC50 = 272 nM
   TI
   LI
   LO
   TS
CP0166284
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-5-tert-butyl-2-methylpyrazole-3-carboxamide
   Show/Hide
C27H29N9O
 1
1
IC50 = 332 nM
   TI
   LI
   LO
   TS
CP0166278
N-[3-[[1-[6-[4-(dimethylamino)butylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H33F3N8O
 1
1
IC50 = 399 nM
   TI
   LI
   LO
   TS
CP0268700
N-[3-[[1-[6-(2-hydroxyethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C28H24F3N7O2
 1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0388616
3-(3,4-dimethoxyphenyl)-5-(1-methylpiperidin-4-yl)oxy-6-phenylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C26H29N5O3
 1
1
IC50 = 410 nM
   TI
   LI
   LO
   TS
CP0166372
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-methoxyphenyl)-4-methylbenzamide
   Show/Hide
C26H23N7O2
 1
1
IC50 = 437 nM
   TI
   LI
   LO
   TS
CP0358252
N-[3-[[1-[6-(4-aminobutylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C30H29F3N8O
 1
1
IC50 = 457 nM
   TI
   LI
   LO
   TS
CP0181870
3-(1-(6-(2-cyanoethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C29H23F3N8O
 1
1
IC50 = 468 nM
   TI
   LI
   LO
   TS
CP0289530
N-[3-[[1-[6-[(4-aminocyclohexyl)amino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O
 1
1
IC50 = 547 nM
   TI
   LI
   LO
   TS
CP0166277
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-chloropyridine-4-carboxamide
   Show/Hide
C24H19ClN8O
 1
1
IC50 = 595 nM
   TI
   LI
   LO
   TS
CP0298947
N-[3-[[1-[6-[2-(diethylamino)ethylamino]pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H33F3N8O
 1
1
IC50 = 642 nM
   TI
   LI
   LO
   TS
CP0289528
N-[4-methyl-3-[[1-[6-(2-pyrrolidin-2-ylethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O
 1
1
IC50 = 818 nM
   TI
   LI
   LO
   TS
CP0290251
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-m-tolylbenzamide
   Show/Hide
C26H23N7O
 1
1
IC50 = 1079 nM
   TI
   LI
   LO
   TS
CP0289196
N-[3-[[1-[6-(3-aminopropylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C29H27F3N8O
 1
1
IC50 = 1117 nM
   TI
   LI
   LO
   TS
CP0166374
4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-m-tolylbenzamide
   Show/Hide
C34H39N9O
 1
1
IC50 = 1228 nM
   TI
   LI
   LO
   TS
CP0019908
BDBM50242742
   Show/Hide
C30H40ClN7O3S
 1
1
IC50 = 1308 nM
   TI
   LI
   LO
   TS
CP0166280
3-(1-(6-(4-(diethylamino)butylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-m-tolylbenzamide
   Show/Hide
C34H40N8O
 1
1
IC50 = 1315 nM
   TI
   LI
   LO
   TS
CP0166379
3-(1-(6-(4-(dimethylamino)butylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-m-tolylbenzamide
   Show/Hide
C32H36N8O
 1
1
IC50 = 1384 nM
   TI
   LI
   LO
   TS
CP0150281
N-[4-methyl-3-[[1-[6-[(1-methylpiperidin-4-yl)amino]pyrimidin-4-yl]benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C32H31F3N8O
 1
1
IC50 = 1422 nM
   TI
   LI
   LO
   TS
CP0166285
N-[3-[[1-[6-(2-aminoethylamino)pyrimidin-4-yl]benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C28H25F3N8O
 1
1
IC50 = 1471 nM
   TI
   LI
   LO
   TS
CP0388615
3-(3,4-dimethoxyphenyl)-5-(1-methylpiperidin-4-yl)oxy-6-(1,3-thiazol-2-yl)pyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C23H26N6O3S
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0150285
4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-m-tolylbenzamide
   Show/Hide
C33H37N9O
 1
1
IC50 = 1658 nM
   TI
   LI
   LO
   TS
CP0661487
3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea monophosphate
   Show/Hide
C26H34Cl2N7O7P
 1
1
IC50 = 3019 nM
   TI
   LI
   LO
   TS
CP0289192
N-[3-[[1-(6-chloropyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C26H18ClF3N6O
 1
1
IC50 = 3296 nM
   TI
   LI
   LO
   TS
CP0385508
2-[4-[4-[6-[(2R)-2-(3-fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperazin-1-yl]acetic acid
   Show/Hide
C27H28FN7O2
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0147358
N-[3-[[1-(6-aminopyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3,5-dichlorobenzamide
   Show/Hide
C25H19Cl2N7O
 1
1
IC50 = 3608 nM
   TI
   LI
   LO
   TS
CP0385511
1-[4-[6-[(2R)-2-(3-fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperidin-4-ol
   Show/Hide
C26H27FN6O
 1
1
IC50 = 4900 nM
   TI
   LI
   LO
   TS
CP0138866
1-[4-[3-[4-amino-5-(2-fluoro-5-hydroxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone
   Show/Hide
C22H25FN6O2
 1
1
IC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0269791
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-phenylbenzamide
   Show/Hide
C25H21N7O
 1
1
IC50 = 5512 nM
   TI
   LI
   LO
   TS
CP0395047
6-[(2R)-2-(3-fluorophenyl)pyrrolidin-1-yl]-3-pyridin-2-ylimidazo[1,2-b]pyridazine
   Show/Hide
C21H18FN5
 1
1
IC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0388864
4-[6-(benzylamino)imidazo[1,2-b]pyridazin-3-yl]benzonitrile
   Show/Hide
C20H15N5
 1
1
IC50 = 7500 nM
   TI
   LI
   LO
   TS
CP0166373
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(isoquinolin-5-yl)-4-methylbenzamide
   Show/Hide
C28H22N8O
 1
1
IC50 = 7836 nM
   TI
   LI
   LO
   TS
CP0166282
3-(1-(6-amino-5-methylpyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide
   Show/Hide
C27H22F3N7O
 1
1
IC50 = 8012 nM
   TI
   LI
   LO
   TS
CP0147360
N-[4-methyl-3-[[1-(6-morpholin-4-ylpyrimidin-4-yl)benzimidazol-2-yl]amino]phenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C30H26F3N7O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0166279
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-4-methyl-N-(2-methylpyridin-4-yl)benzamide
   Show/Hide
C25H22N8O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0166371
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-chlorophenyl)-4-methylbenzamide
   Show/Hide
C25H20ClN7O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0166377
N-[3-[[1-(6-methoxypyrimidin-4-yl)benzimidazol-2-yl]amino]-4-methylphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C27H21F3N6O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0281287
3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)-N-(3-carbamoylphenyl)-4-methylbenzamide
   Show/Hide
C26H22N8O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0007430
IBRUTINIB
   Show/Hide
C25H24N6O2
 3
1 IC50 = 16.2 nM
2 IC50 = 200 nM
3 Ki = 14 nM
CP0378468
(S)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide
   Show/Hide
C30H31F3N8O
 1
1 IC50 = 19 nM
CP0661487
3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea monophosphate
   Show/Hide
C26H34Cl2N7O7P
 1
1 IC50 = 300 nM
CP0075633
(E)-4-(dimethylamino)-N-[7-fluoro-4-(2-methylanilino)imidazo[1,5-a]quinoxalin-8-yl]-N-methylbut-2-enamide
   Show/Hide
C24H25FN6O
 1
1 IC50 = 624 nM
CP0019908
BDBM50242742
   Show/Hide
C30H40ClN7O3S
 1
1 Kd = 280 nM
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O
 2
1 Kd = 890 nM
2 Kd > 10000 nM
Clinical Information about the Protein
Target 1 ( Tyrosine-protein kinase Lyn (JTK8) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Bone disease [ICD-11: FC0Z]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 Bafetinib Phase 2
Bone disease
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT02084 Tyrosine-protein kinase Lyn Mus musculus, Mouse